Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-15
2009-08-11
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S225000
Reexamination Certificate
active
07572814
ABSTRACT:
Certain 3,5-dibenzoyl-4-phenyl-piperidine compounds and salts thereof are provided herein. The compounds and salts may be useful in causing mitotic arrest and cell death. Also provided herein are certain pharmaceutical compositions comprising 3,5-dibenzoyl-4-phenyl-piperidine compounds or salts thereof and certain methods of use thereof.
REFERENCES:
patent: 3932645 (1976-01-01), Meyer et al.
patent: 4492703 (1985-01-01), Goldmann et al.
patent: 4495192 (1985-01-01), Muto et al.
patent: 4766213 (1988-08-01), Juraszyk et al.
patent: 6977264 (2005-12-01), Fotsch et al.
patent: 2007/0161683 (2007-07-01), Collibee et al.
Hodgkinson, et. al. “Chemical synthesis and mode of action of the azinomycins” Tetrahedron 2001, 57, 4467-4488.
Smith, A. B. et. al. “(D)-Discodermolide: total synthesis, construction of novel analogues, and biological evaluation.” Tetrahedron 2008, 64, 261-298.
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
International Search Report and Written Opinion mailed Oct. 2, 2007, for international application No. PCT/US2006/044753, filed Nov. 15, 2006.
M.V. Denisenko, G.V. Pavel and M.N. Tilichenko;Synthesis of hydrogenated heterocyclic compounds from alpha-methylene-1,5-diketones. 5. Synthesis and stereochemistry of the products of addition of hydrazines to 2,4-dibenzoyl-3-phenyl-1,4-pentadiene; Journal Khymiya Geterotsiklicheskikh Soedinenii, No. 6, pp. 789-791, Jun. 1981.
M.V. Denisenko, G.V. Pavel and M.N. Tilichenko;Synthesis and stereochemistry of N-substituted 3,5-dibenzoyl-4-phenylpiperidines; Journal Khymiya Geterotsiklicheskikh Soedinenii, No. 2, pp. 235-239, Feb. 1979.
Mi Jung Lee, Ka Young Lee, and Jae Nyoung Kim;Synthesis of N-benzyl 3,5-disubstituted piperidines via double Michael addition strategy; Bulletin Korean Chem. Soc. 2005, vol. 26, No. 3, pp. 477-480.
G.V. Pavel, N.P. Bagrina, and M.N. Tilichenko;Synthesis of hydrogenated heterocyclic compounds from alpha-methylidene-1,5-diketones. 4. Hydropyridines based on the reaction of 1,3,5-triphenyl-2-aminomethyl-4-methylidene-1,5-pentadione with primary amines; Journal Khymiya Geterotsiklicheskikh Soedinenii, No. 10, pp. 1374-1376, Oct. 1979.
G.V. Pavel, M.N. Tilichenko, and M.V. Denisenko;Synthesis of a new form of 1,5-diketones of the piperidine series, Journal Khymiya Geterotsiklicheskikh Soedinenii, No. 7, p. 999, Jul. 1976.
International Search Report and Written Opinion mailed Oct. 2, 2007, for international application No. PCT/US2006/044154, filed Nov. 14, 2006.
International Search Report and Written Opinion mailed Jul. 30, 2008, for international application No. PCT/US2008/006046, filed May 9, 2008.
Office Action mailed Aug. 19, 2008, for U.S. Appl. No. 11/600,014, filed Nov. 14, 2006.
Furdik et al. STN Accession No. 1964:476455; Document No. 61:76455 (1964).
STN Accession No. 1983:215488, Document No. 98:215488 (1983).
Katritzky et al. STN Accession No. 1987:438861, Document No. 107:38861 (1986).
Gunics et al. STN Accession No. 2001:294514, Document No. 135:220668 (2001).
Agamya et al., STN Accession No. 2001:854410, Document No. 136:263072 (2001).
Kawase et al., STN Accession No. 2002:106233, Document No. 137:41257 (2002).
Saponara et al., STN Accession No. 2004:187287, Document No. 140:368096 (2004).
Saponara et al.,British J. Pharmacology, 141:415-422 (2004).
Ashcraft Luke
Bergnes Gustave
Collibee Scott
Morgan Bradley P.
Morgans, Jr. David J.
Cytokinetics, Incorporated
Desai Rita J
Finnegan Henderson Farabow Garrett & Dunner LLP
O'Dell David K
LandOfFree
3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4125154